GM-XANTHO has completed CMC, which has manufactured in accordance with GMP/PIS specifications. GM-XANTHO has completed pre-clinical pharmacology, pharmacokinetics and toxicity tests to confirm the efficacy of GM-XANTHO in the treatment of atopic dermatitis and has low side effects.